Statistical analysis plan for the ‘Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage’ (TICH-2) trial

Statistical analysis plan for the ‘Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage’ (TICH-2) trial

Abstract Rationale Aside from blood pressure lowering, treatment options for intracerebral haemorrhage remain limited and a proportion of patients will undergo early haematoma expansion with resultant significant morbidity and mortality. Tranexamic acid (TXA), an anti-fibrinolytic drug, has been sho...

Full description

Bibliographic Details
Main Authors: Katie Flaherty, Philip M. Bath, Robert Dineen, Zhe Law, Polly Scutt, Stuart Pocock, Nikola Sprigg, on behalf of the TICH-2 investigators
Format: Article
Language:English
Published: BMC 2017-12-01
Series:Trials
Subjects:
Hyperacute
Spontaneous intracerebral haemorrhage
Tranexamic acid
Randomised trial
Placebo-controlled
Online Access:http://link.springer.com/article/10.1186/s13063-017-2341-5

Internet

http://link.springer.com/article/10.1186/s13063-017-2341-5

Similar Items